In vitro activity of cefbuperazone and other antimicrobial agents against isolates from the female genital tract
Open Access
- 1 June 1985
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 27 (6) , 958-960
- https://doi.org/10.1128/aac.27.6.958
Abstract
Cefbuperazone (BMY 25182), a new cephamycin, showed activity similar to those of moxalactam and other cephalosporin-cephamycins against aerobic and anaerobic bacteria from female genital tract infections. MICs of the antimicrobial agents were less than or equal to 16 micrograms/ml for greater than 97% of organisms tested. All of the anaerobic bacteria tested were susceptible to clindamycin, metronidazole, and chloramphenicol.Keywords
This publication has 6 references indexed in Scilit:
- Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infectionsAmerican Journal of Obstetrics and Gynecology, 1983
- CEFOTAXIME SODIUM THERAPY FOR ENDOMYOMETRITIS FOLLOWING CESAREAN-SECTION - DOSE-FINDING AND COMPARATIVE STUDIES1983
- In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibioticAntimicrobial Agents and Chemotherapy, 1982
- In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infectionsAntimicrobial Agents and Chemotherapy, 1982
- Moxalactam for obstetric and gynecologic infectionsAmerican Journal of Obstetrics and Gynecology, 1981
- CEFOXITIN - SINGLE-AGENT TREATMENT OF MIXED AEROBIC-ANAEROBIC PELVIC INFECTIONS1979